Literature DB >> 12110409

The impact of osteoporosis on quality-of-life: the OFELY cohort.

A R Martin1, E Sornay-Rendu, J M Chandler, F Duboeuf, C J Girman, P D Delmas.   

Abstract

Although the long-term outcomes of osteoporosis (Op) such as fracture, kyphosis, and pain are well known, the physical, psychological, and social consequences, beyond fracture and pain, are less clear. The Osteoporosis-targeted Quality-of-life (OPTQoL) questionnaire aimed at assessing the physical difficulty, fears, and adaptations to one's daily life was developed as a cross-sectional instrument to characterize the burden of Op within a community. The purpose of this study was to assess the impact of Op and related factors on community women participating in the OFELY study in France. Femoral neck bone mineral density (BMD) and OPTQoL questionnaire data were collected from women randomly selected from a large insurance company. Data were obtained for 756 women (mean age 59 years, range 36-92), most of whom were white. Women were classified into five groups based on the extent of physical manifestations and family history of Op. Women who had prior fractures, height loss, and/or kyphosis or both reported greater physical difficulty, more adaptations to their lives, and greater fears than women reporting no such changes. Scores on the Physical Difficulty domain, however, did not differ significantly based on BMD alone (BMD T score <or=2.5), after controlling for age and self-reported arthritis. The negative impact of Op on quality-of-life (QoL) seems to be more related to the physical manifestations of Op than to bone density levels. Recognition of the impact of Op-related factors on QoL may help health-care providers more fully appreciate the importance of prevention and treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12110409     DOI: 10.1016/s8756-3282(02)00787-1

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  51 in total

1.  Monthly or weekly bisphosphonate? Evaluation of satisfaction in patients with postmenopausal osteoporosis using OPSAT-Q questionnaire during the BOOSTER study in Croatia.

Authors:  Tonko Vlak; Darko Kaštelan; Petar Lozo; Jure Aljinović; Marina Gradišer; Sime Mijić; Tatjana Nikolić; Blaženka Miškić; Dolores Car; Gordana Tajšić; Tina Dušek; Zrinka Jajić; Frane Grubišić; Tamara Poljičanin; Miro Bakula; Feđa Džubur; Matilda Strižak-Ujević; Mira Kadojić; Maja Radman; Maja Vugrinec; Zeljka Kuster; Marijeta Pekez; Endi Radović; Ljubica Labar; Zeljka Crnčević-Orlić; Mirko Koršić
Journal:  Clin Rheumatol       Date:  2011-09-29       Impact factor: 2.980

2.  Risk factors for 5-year prospective height loss among postmenopausal women.

Authors:  Xiaodan Mai; Britt Marshall; Kathleen M Hovey; Jill Sperrazza; Jean Wactawski-Wende
Journal:  Menopause       Date:  2018-08       Impact factor: 2.953

Review 3.  [New techniques for the diagnosis of osteoporosis].

Authors:  A S Issever; T M Link
Journal:  Radiologe       Date:  2006-10       Impact factor: 0.635

Review 4.  Impact of metabolic complications on antiretroviral treatment adherence: clinical and public health implications.

Authors:  Jean B Nachega; Maria Paola Trotta; Mark Nelson; Adriana Ammassari
Journal:  Curr HIV/AIDS Rep       Date:  2009-08       Impact factor: 5.071

5.  Detective value of historical height loss and current height/knee height ratio for prevalent vertebral fracture in Japanese postmenopausal women.

Authors:  Kousei Yoh; Akiko Kuwabara; Kiyoshi Tanaka
Journal:  J Bone Miner Metab       Date:  2014-09       Impact factor: 2.626

Review 6.  Clinical effects of strontium ranelate in women with postmenopausal osteoporosis.

Authors:  Pierre D Delmas
Journal:  Osteoporos Int       Date:  2005-01       Impact factor: 4.507

7.  Awareness and health beliefs of women towards osteoporosis.

Authors:  Seang-Mei Saw; Ching-Ye Hong; Jeanette Lee; Mee-Lian Wong; Mei-Fen Chan; Angela Cheng; Keng-Hong Leong
Journal:  Osteoporos Int       Date:  2003-06-26       Impact factor: 4.507

Review 8.  The impact of fragility fracture on health-related quality of life : the importance of antifracture therapy.

Authors:  Ted Xenodemetropoulos; Shawn Davison; George Ioannidis; Jonathan D Adachi
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  Impact of postural deformities and spinal mobility on quality of life in postmenopausal osteoporosis.

Authors:  N Miyakoshi; E Itoi; M Kobayashi; H Kodama
Journal:  Osteoporos Int       Date:  2003-10-14       Impact factor: 4.507

10.  Alendronate improves QOL of postmenopausal women with osteoporosis.

Authors:  Hisaya Kawate; Keizo Ohnaka; Masahiro Adachi; Suminori Kono; Hideyuki Ikematsu; Hisashi Matsuo; Kazumi Higuchi; Takehiko Takayama; Ryoichi Takayanagi
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.